Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

Transplant International

Volumn 25, Issue 4, 2012, Pages 448-454

  Giannelli, Valerio ^a   Giusto, Michela ^a   Farcomeni, Alessio ^b   Ponziani, Francesca R ^c   Pompili, Maurizio ^c   Viganò, Raffaella ^d   Iemmolo, Rosa Maria ^e   Donato, Maria F ^f   Rendina, Maria ^g   Toniutto, Pierluigi ^h   Pasulo, Luisa ⁱ   Morelli, Maria Cristina ^j   De Martin, Eleonora ^k   Miglioresi, Lucia ^l   Di Paolo, Daniele ^m   Fagiuoli, Stefano ⁱ   Merli, Manuela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h UNIVERSITY OF UDINE   (Italy)

ⁱ OSPEDALI RIUNITI   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k UNIVERSITY OF PADOVA   (Italy)

^l SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^m UNIVERSITY OF ROME TOR VERGATA   (Italy)

more..

Author keywords

adherence; antiviral treatment; gender; HCV; liver transplant

Indexed keywords

CYCLOSPORIN; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; PEGINTERFERON; RIBAVIRIN; TACROLIMUS;

ADULT; AGED; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SIDE EFFECT;

ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POLYETHYLENE GLYCOLS; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; SEX FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84858443752     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01440.x     Document Type: Article

References (22)

1. Thuluvath PJ, Krok KL, Segev DL, Yoo HY,. Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States. Liver Transpl 2007; 13: 719.
2. Berenguer M,. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8: 14.
3. Gane EJ,. The natural history of recurrent hepatitis C and what influences this. Liver Transpl 2008; 14: 36.
4. Firpi RJ, Clark V, Soldevila-Pico C, et al. The natural history of hepatitis C cirrhosis after liver transplantation. Liver Transpl 2009; 15: 1063.
5. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR,. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889.
6. Barrett S, Goh J, Coughlan B, et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001; 49: 423.
7. Pagliaro L, Peri V, Linea C, Cammà C, Giunta M, Magrin S,. Natural history of chronic hepatitis C. Ital J Gastroenterol Hepatol 1999; 31: 28.
8. Leone N, Rizzetto M,. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol 2005; 51: 31.
9. Belli LS, Burroughs AK, Burra P, et al. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl 2007; 13: 733.
10. Walter T, Dumortier J, Guillaud O, Hervieu V, Scoazec JY, Boillot O,. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center. Liver Transpl 2007; 13: 294.
11. Lai JC, Verna EC, Brown Jr RS, et al. Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology 2011; 54: 418.
12. Lai JC, Feng S, Roberts JP, Terrault NA,. Gender differences in liver donor quality are predictive of graft loss. Am J Transplant 2011; 11: 296.
13. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-14.
14. McHutchison JG, Manns M, Patel K, et al. Adherence to combination therapy enhances sustained response in genotype 1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123: 1061.
15. Di Martino V, Lebray P, Myers RP, et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2004; 40: 1426.
16. Villa E, Karampatou A, Cammà C, et al. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastroenterology 2011; 140: 818.
17. Neuman MG, Benhamou JP, Malkiewicz IM, et al. Cytokines as predictors for sustained response and as markers for immuno-modulation in patients with chronic hepatitis C. Clin Biochem 2001; 34: 173.
18. Berenguer M,. Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. J Hepatol 2008; 49: 274.
19. Gordon FD, Kwo P, Vargas HE,. Treatment of hepatitis C in liver transplant recipients. Liver Transpl 2009; 15: 126.
20. Charlton MR, Thompson A, Veldt BJ, et al. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology 2011; 53: 317.
21. Lange CM, Moradpour D, Doehring A, et al. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. J Hepatol 2010; 55: 322.
22. Bitetto D, Fabris C, Fornasiere E, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011; 24: 43.